Slika omota

Survival Outcomes Between Clear Cell and Non-Clear Cell Epithelial Ovarian Cancer

Objective: To compare the 5-year survival rates of women with clear cell (CCC) versus those with non-clear cell (non-CCC) epithelial ovarian cancer.Materials and Methods: Retrospective study was performed on patients with epithelial ovarian cancer who had undergone treatment at Rajavithi Hospital fr...

Spremljeno u:

Bibliografski detalji
Glavni autori:	Wasanai Jermsirisakpong (Autor), Suphet Tuipae (Autor)
Format:	Knjiga
Izdano:	The Royal Thai College of Obstetricians and Gynaecologists, 2013-03-01T00:00:00Z.
Teme:	article
Online pristup:	Connect to this object online.
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti

Aspirin use correlates with survival in women with clear cell ovarian cancer
od: Alyssa M. Wield, i dr.
Izdano: (2018)

CLINICAL CHARACTERISTICS OF OVARIAN CLEAR CELL CANCER
od: M. D. Akhmedova, i dr.
Izdano: (2014)

Treatment results and prognostic factors of clear cell ovarian carcinomas and ovarian carcinomas with clear cell component
od: M. D. Ahmedova, i dr.
Izdano: (2014)

The role of α2,3-linked sialylation on clear cell type epithelial ovarian cancer
od: Pi-Lin Sung, i dr.
Izdano: (2018)

Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma
od: Qian Chen, i dr.
Izdano: (2020)

Construction of a Prediction Model of Cancer-Specific Survival after Ovarian Clear Cell Carcinoma Surgery
od: Mengqi Huang, i dr.
Izdano: (2024)

Two cases of clear cell ovarian cancer in young patients
od: Mahdieh Rajabi-Moghaddam, i dr.
Izdano: (2016)

Ovarian clear cell carcinoma with uterine intramural recurrence: Case report of ovarian clear cell carcinoma with fertility sparing treatment
od: Ting Yu Chang, i dr.
Izdano: (2024)

Childhood Clear Cell Sarcoma of Kidney: Incidence and Survival
od: Hui Gao, i dr.
Izdano: (2021)

Non-diethylstilbestrol exposed vaginal clear cell adenocarcinoma has a common molecular profile with ovarian clear cell adenocarcinoma: A case report
od: Yuji Ikeda, i dr.
Izdano: (2014)

SOX17 expression in ovarian clear cell carcinoma
od: Daichi Kodama, i dr.
Izdano: (2024)

Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma
od: Tsukuru Amano, i dr.
Izdano: (2021)

Clear cell sarcoma
od: Pinar Ozuguz, i dr.
Izdano: (2014)

Clear cell calcifying epithelial odontogenic tumor: A rare case report
od: Jincy Thomas, i dr.
Izdano: (2008)

Peripheral variant of calcifying epithelial odontogenic tumor with clear cell changes: An enigma
od: Manas Bajpai
Izdano: (2018)

Maternal and Neonatal Outcomes of Repeated Cesarean Delivery: A Comparison between Transverse and Vertical Skin Incision
od: Anutsara Promket, i dr.
Izdano: (2016)

Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapy
od: Blair McNamara, i dr.
Izdano: (2023)

Metastatic Ovarian Clear Cell Carcinoma in the Context of In Vitro Fertilization Pregnancy
od: Arati Inamdar, i dr.
Izdano: (2020)

Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination
od: Eriko Nakamura, i dr.
Izdano: (2015)

Gene set-based integrative analysis of ovarian clear cell carcinoma
od: Chia-Ming Chang, i dr.
Izdano: (2016)

Clear cell odontogenic carcinoma versus hyalinizing clear cell carcinoma: A diagnostic dilemma
od: Rama Raju Devaraju, i dr.
Izdano: (2014)

Loss of clear cell characteristics in aggressive clear cell odontogenic carcinoma: a case report
od: Yanan Sun, i dr.
Izdano: (2024)

Subungual clear cell acanthoma
od: Chun-Yu Cheng, i dr.
Izdano: (2014)

The iron-modulating hormone hepcidin is upregulated and associated with poor survival outcomes in renal clear cell carcinoma
od: Jian Huang, i dr.
Izdano: (2022)

From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer
od: Zesi Liu, i dr.
Izdano: (2024)

Omission of adjuvant therapy in stage I clear cell ovarian cancer: Review of the BC Cancer experience
od: Shiru L. Liu, i dr.
Izdano: (2020)

The pathomorphological characteristics of clear-cell adenocarcinomas of the ovary and its mixed tumors with a clear-cell component
od: M.. D Akhmedova, i dr.
Izdano: (2014)

Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR
od: Wenwen Chien, i dr.
Izdano: (2023)

Ovarian Clear Cell Carcinoma with Functioning Stroma and Associated Endometrial Intraepithelial Neoplasia
od: Fabian Desimpel, i dr.
Izdano: (2022)

Impact of the number of cycles of platinum-based chemotherapy for early stage ovarian clear cell carcinoma on survival: a retrospective study
od: Yang Gao
Izdano: (2023)

A case of ovarian clear cell carcinoma arising from ovarian mature cystic teratoma
od: Kazuya Maeda, i dr.
Izdano: (2018)

Renal cell carcinoma: evolving approaches to advanced non-clear cell carcinoma
od: Daniel Y.C. Heng, i dr.
Izdano: (2011)

Renal cell carcinoma: evolving approaches to advanced non-clear cell carcinoma
od: Daniel Y.C. Heng, i dr.
Izdano: (2011)

Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma
od: Junhui Hu, i dr.
Izdano: (2019)

High expression of Aldolase A predicts poor survival in patients with clear-cell renal cell carcinoma
od: Na N, i dr.
Izdano: (2017)

Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma
od: Martyna Parol‐Kulczyk, i dr.
Izdano: (2024)

Development of an Interferon Gamma Response-Related Signature for Prediction of Survival in Clear Cell Renal Cell Carcinoma
od: Liu L, i dr.
Izdano: (2021)

Clear Cell Adenocarcinoma of the Uterine Cervix
od: Chun-Wei Chen, i dr.
Izdano: (2007)

Clear cell myoepithelioma of the hard palate
od: A.K. Agarwal, i dr.
Izdano: (2016)

Multiple eruptive clear cell acanthoma
od: Sha Zhou, i dr.
Izdano: (2018)